Medical Aspects of Chemical Warfare (2008) - The Black Vault
Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault
Riot Control AgentsChapter 13Riot Control AgentsHarry Salem, PhD*; Bradford W. Gutting, PhD † ; Timothy A. Kluchinsky, Jr, phD, MSPH ‡ ; Charles H.Boardman § ; Shirley D. Tuorinsky, MSN ¥ ; a n d Joseph J. Hout INTRODUCTIONHISTORYCS (o-chlorobenzylidene malononitrile)Physical Characteristics and DeploymentThermal Degradation ProductsClinical EffectsOC (oleoresin capsicum)Physical Characteristics and DeploymentPhysiological EffectsClinical EffectsOTHER RIOT CONTROL COMPOUNDSPS (Chloropicrin )CN (1-Chloroacetophenone)DM (Diphenylaminearsine)CR (Dibenz(b,f)(1,4)oxazepine)MEDICAL CAREPersonal ProtectionDecontaminationTreatmentNew Developments and Future UseSUMMARY*Chief Scientist for Life Sciences; US Army Edgewood Chemical and Biological Center, 5183 Blackhawk Road, Aberdeen Proving Ground, Maryland21010† Toxicologist; Naval Surface Warfare Center; Dahlgren Division (NSWCDD); Chemical, Biological, Radiological Defense Division (Code B54); Dahlgren,Virginia 22448‡ Manager, Health Hazard Assessment Program, Directorate of Occupational Health Sciences, US Army Center for Health Promotion and PreventiveMedicine, 5158 Blackhawk Road, Aberdeen Proving Ground, Maryland 21010-5403§ Lieutenanat Colonel, Biomedical Sciences Corps, US Air Force; Instructor / Air Force Liaison and Occupational Therapist, US Army Medical ResearchInstitute of Chemical Defense, 3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010-5400¥ Lieutenant Colonel, AN, US Army; Executive Officer, Comabat Casualty Care Division, US Army Medical Research Institute of Chemical Defense,3100 Ricketts Point Road, Aberdeen Proving Ground, Maryland 21010-5400 Researcher, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, Maryland 20814441
Medical Aspects of Chemical WarfareINTRODUCTIONThe 1993 Chemical Weapons Convention treatydefines riot control agents (RCAs) as agents that canrapidly produce sensory irritation or disabling physicaleffects in humans that disappear within a short timefollowing termination of exposure. 1 More specifically,these are chemical agents that are designed to causetemporary incapacitation of the individual throughintense irritation of tissues and the creation of a strongsensation of discomfort, including difficulty breathingand pain, without causing long-term disabilityor death. These disabling physiological effects occurwhen RCAs come into contact with the sensory nervereceptors at the site of contamination, resulting in localpain and discomfort with associated reflexes.RCAs include chemicals from the following pharmacologicalclasses: irritants, lachrymators, sternutators,emetics, sedatives, hypnotics, serotonin antagonists,hypotensives, thermoregulatory disruptors, nauseants,vision disruptors, neuromuscular blockers, andmalodorous substances. 2 They are considered harassingagents, nonlethal or less than lethal agents, and althoughnot gases, they are usually referred to as tear gas. 3 RCAsare relatively safe to use, especially when used in theopen air, but have been known to cause death on occasion,particularly when used in close confines with inadequateventilation or when the exposed individual waspredisposed to cardiorespiratory compromise throughdisease or heavy intoxication with drugs or alcohol.Like other chemical agents, RCAs are designated withNorth Atlantic Treaty Organization (NATO) letter codesto label and help distinguish them. The agents coveredin this chapter are those that have been used, or allegedlyused, since World War II; their chemical names andrespective NATO codes are o-chlorobenzylidene malononitrile(CS); oleoresin capsicum (OC); chloropicrin(PS); 1-chloroacetophenone (CN), diphenylaminearsine(DM), and dibenz(b,f)(1,4)oxazepine (CR).Characteristics common to all of the agents discussedin this chapter are• a rapid time of onset of effects (seconds to afew minutes);• a relatively brief duration of effects (15–30minutes) in most cases, once the exposedindividual exits the contaminated area and isdecontaminated (ie, the material is removedfrom the victim’s clothing and skin); and• a high safety ratio, that is, a relatively lowdose of these agents is needed to cause tissueirritation or pain (effective dose or effectiveconcentration), but a significantly larger doseis required to cause death (lethal dose or lethalconcentration, LCt 50). 2–4This chapter will cover only RCAs that have beenpurposefully or allegedly used in recent history. Becauseof their prevalent use, CS and OC will be coveredin greater detail than other agents.Although the effects differ slightly among thevarious agents, all RCAs cause some form of eye irritationinvolving lacrimation and blepharospasm,which causes the eyes to close temporarily, renderingvictims unable to see and dramatically reducingtheir ability to resist. PS, CN, CS, CR, DM, and OCalso cause irritation to airways resulting in coughing,shortness of breath, and retching or vomiting. 3 DM ineffective doses causes significant vomiting with resultingmental depression and malaise. These agentscause some degree of pain sensation either throughirritation of peripheral nerve endings in tissue, suchas the mucous membranes and skin (PS, CN, CS, CR),or by causing the sudden release of neurotransmitters,such as bradykinin or substance P, which signal thesensation of intense pain (OC). 2The reflex most associated with death from theinhalation exposure of irritants is the Kratschmer reflex,first reported in 1870 as the immediate responseof apnea or cessation of respiration in rabbits followingexposure to chemical irritants such as chloroformand carbon dioxide. 5 The response is a protectivereflex or defense mechanism to prevent or reducethe amount of noxious chemical reaching the lowerrespiratory tract and maintain homeostasis. Accompaniedby bradycardia and a biphasic fall and rise inaortic blood pressure, the reflex is mediated by theolfactory (I), trigeminal (V), and glossopharyngeal(IX) cranial nerves. It has also occurred in rodent andcanine experiments following exposure to volatilesolvents and was demonstrated to occur in humans. 6The cardiopulmonary receptors involved in the reflexprevent the absorption and distribution of the inhaledirritant to the vital organs, as well as facilitating theexpulsion of the irritant, and the extracardiopulmonarymechanisms promote metabolism and excretion of theabsorbed chemical. These effects have been describedby Aviado and Salem and by Aviado and Aviado. 7–9During apnea or cessation of respiration, blood levelsof carbon dioxide increase and drive the respiratorycenter to restart breathing. Individuals with compromisedimmune systems, nervous system depressionas a result of alcohol or illicit drug consumption, or acombination of these, may not be able to restart respirationand die from asphyxia. The Kratschmer reflexmay be responsible in part for some in-custody deathsattributed by law enforcement agencies to positionalasphyxia following the initial use of pepper sprays inthe United States in the early 1990s. 2442
- Page 413 and 414: Medical Aspects of Chemical Warfare
- Page 415 and 416: Medical Aspects of Chemical Warfare
- Page 417 and 418: Medical Aspects of Chemical Warfare
- Page 419 and 420: Medical Aspects of Chemical Warfare
- Page 421 and 422: Medical Aspects of Chemical Warfare
- Page 423 and 424: Medical Aspects of Chemical Warfare
- Page 425 and 426: Medical Aspects of Chemical Warfare
- Page 427 and 428: Medical Aspects of Chemical Warfare
- Page 429 and 430: Medical Aspects of Chemical Warfare
- Page 431 and 432: Medical Aspects of Chemical Warfare
- Page 433 and 434: Medical Aspects of Chemical Warfare
- Page 435 and 436: Medical Aspects of Chemical Warfare
- Page 437 and 438: Medical Aspects of Chemical Warfare
- Page 439 and 440: Medical Aspects of Chemical Warfare
- Page 441 and 442: Medical Aspects of Chemical Warfare
- Page 443 and 444: Medical Aspects of Chemical Warfare
- Page 445 and 446: Medical Aspects of Chemical Warfare
- Page 447 and 448: Medical Aspects of Chemical Warfare
- Page 449 and 450: Medical Aspects of Chemical Warfare
- Page 451 and 452: Medical Aspects of Chemical Warfare
- Page 453 and 454: Medical Aspects of Chemical Warfare
- Page 455 and 456: Medical Aspects of Chemical Warfare
- Page 457 and 458: Medical Aspects of Chemical Warfare
- Page 459 and 460: Medical Aspects of Chemical Warfare
- Page 461 and 462: Medical Aspects of Chemical Warfare
- Page 463: Medical Aspects of Chemical Warfare
- Page 467 and 468: Medical Aspects of Chemical Warfare
- Page 469 and 470: Medical Aspects of Chemical Warfare
- Page 471 and 472: Medical Aspects of Chemical Warfare
- Page 473 and 474: Medical Aspects of Chemical Warfare
- Page 475 and 476: Medical Aspects of Chemical Warfare
- Page 477 and 478: Medical Aspects of Chemical Warfare
- Page 479 and 480: Medical Aspects of Chemical Warfare
- Page 481 and 482: Medical Aspects of Chemical Warfare
- Page 483 and 484: Medical Aspects of Chemical Warfare
- Page 485 and 486: Medical Aspects of Chemical Warfare
- Page 487 and 488: Medical Aspects of Chemical Warfare
- Page 489 and 490: Medical Aspects of Chemical Warfare
- Page 491 and 492: Medical Aspects of Chemical Warfare
- Page 493 and 494: Medical Aspects of Chemical Warfare
- Page 495 and 496: Medical Aspects of Chemical Warfare
- Page 497 and 498: Medical Aspects of Chemical Warfare
- Page 499 and 500: Medical Aspects of Chemical Warfare
- Page 501 and 502: Medical Aspects of Chemical Warfare
- Page 503 and 504: Medical Aspects of Chemical Warfare
- Page 505 and 506: Medical Aspects of Chemical Warfare
- Page 507 and 508: Medical Aspects of Chemical Warfare
- Page 509 and 510: Medical Aspects of Chemical Warfare
- Page 511 and 512: Medical Aspects of Chemical Warfare
- Page 513 and 514: Medical Aspects of Chemical Warfare
<strong>Medical</strong> <strong>Aspects</strong> <strong>of</strong> <strong>Chemical</strong> <strong>Warfare</strong>INTRODUCTION<strong>The</strong> 1993 <strong>Chemical</strong> Weapons Convention treatydefines riot control agents (RCAs) as agents that canrapidly produce sensory irritation or disabling physicaleffects in humans that disappear within a short timefollowing termination <strong>of</strong> exposure. 1 More specifically,these are chemical agents that are designed to causetemporary incapacitation <strong>of</strong> the individual throughintense irritation <strong>of</strong> tissues and the creation <strong>of</strong> a strongsensation <strong>of</strong> discomfort, including difficulty breathingand pain, without causing long-term disabilityor death. <strong>The</strong>se disabling physiological effects occurwhen RCAs come into contact with the sensory nervereceptors at the site <strong>of</strong> contamination, resulting in localpain and discomfort with associated reflexes.RCAs include chemicals from the following pharmacologicalclasses: irritants, lachrymators, sternutators,emetics, sedatives, hypnotics, serotonin antagonists,hypotensives, thermoregulatory disruptors, nauseants,vision disruptors, neuromuscular blockers, andmalodorous substances. 2 <strong>The</strong>y are considered harassingagents, nonlethal or less than lethal agents, and althoughnot gases, they are usually referred to as tear gas. 3 RCAsare relatively safe to use, especially when used in theopen air, but have been known to cause death on occasion,particularly when used in close confines with inadequateventilation or when the exposed individual waspredisposed to cardiorespiratory compromise throughdisease or heavy intoxication with drugs or alcohol.Like other chemical agents, RCAs are designated withNorth Atlantic Treaty Organization (NATO) letter codesto label and help distinguish them. <strong>The</strong> agents coveredin this chapter are those that have been used, or allegedlyused, since World War II; their chemical names andrespective NATO codes are o-chlorobenzylidene malononitrile(CS); oleoresin capsicum (OC); chloropicrin(PS); 1-chloroacetophenone (CN), diphenylaminearsine(DM), and dibenz(b,f)(1,4)oxazepine (CR).Characteristics common to all <strong>of</strong> the agents discussedin this chapter are• a rapid time <strong>of</strong> onset <strong>of</strong> effects (seconds to afew minutes);• a relatively brief duration <strong>of</strong> effects (15–30minutes) in most cases, once the exposedindividual exits the contaminated area and isdecontaminated (ie, the material is removedfrom the victim’s clothing and skin); and• a high safety ratio, that is, a relatively lowdose <strong>of</strong> these agents is needed to cause tissueirritation or pain (effective dose or effectiveconcentration), but a significantly larger doseis required to cause death (lethal dose or lethalconcentration, LCt 50). 2–4This chapter will cover only RCAs that have beenpurposefully or allegedly used in recent history. Because<strong>of</strong> their prevalent use, CS and OC will be coveredin greater detail than other agents.Although the effects differ slightly among thevarious agents, all RCAs cause some form <strong>of</strong> eye irritationinvolving lacrimation and blepharospasm,which causes the eyes to close temporarily, renderingvictims unable to see and dramatically reducingtheir ability to resist. PS, CN, CS, CR, DM, and OCalso cause irritation to airways resulting in coughing,shortness <strong>of</strong> breath, and retching or vomiting. 3 DM ineffective doses causes significant vomiting with resultingmental depression and malaise. <strong>The</strong>se agentscause some degree <strong>of</strong> pain sensation either throughirritation <strong>of</strong> peripheral nerve endings in tissue, suchas the mucous membranes and skin (PS, CN, CS, CR),or by causing the sudden release <strong>of</strong> neurotransmitters,such as bradykinin or substance P, which signal thesensation <strong>of</strong> intense pain (OC). 2<strong>The</strong> reflex most associated with death from theinhalation exposure <strong>of</strong> irritants is the Kratschmer reflex,first reported in 1870 as the immediate response<strong>of</strong> apnea or cessation <strong>of</strong> respiration in rabbits followingexposure to chemical irritants such as chlor<strong>of</strong>ormand carbon dioxide. 5 <strong>The</strong> response is a protectivereflex or defense mechanism to prevent or reducethe amount <strong>of</strong> noxious chemical reaching the lowerrespiratory tract and maintain homeostasis. Accompaniedby bradycardia and a biphasic fall and rise inaortic blood pressure, the reflex is mediated by theolfactory (I), trigeminal (V), and glossopharyngeal(IX) cranial nerves. It has also occurred in rodent andcanine experiments following exposure to volatilesolvents and was demonstrated to occur in humans. 6<strong>The</strong> cardiopulmonary receptors involved in the reflexprevent the absorption and distribution <strong>of</strong> the inhaledirritant to the vital organs, as well as facilitating theexpulsion <strong>of</strong> the irritant, and the extracardiopulmonarymechanisms promote metabolism and excretion <strong>of</strong> theabsorbed chemical. <strong>The</strong>se effects have been describedby Aviado and Salem and by Aviado and Aviado. 7–9During apnea or cessation <strong>of</strong> respiration, blood levels<strong>of</strong> carbon dioxide increase and drive the respiratorycenter to restart breathing. Individuals with compromisedimmune systems, nervous system depressionas a result <strong>of</strong> alcohol or illicit drug consumption, or acombination <strong>of</strong> these, may not be able to restart respirationand die from asphyxia. <strong>The</strong> Kratschmer reflexmay be responsible in part for some in-custody deathsattributed by law enforcement agencies to positionalasphyxia following the initial use <strong>of</strong> pepper sprays inthe United States in the early 1990s. 2442